心脏设备可行。但代价是什么呢？ - Suppr

Suppr

超能文献

Yes to cardiac devices. But at what cost?

作者信息

Leyva Francisco

出版信息

Europace. 2013 Mar;15(3):313-4. doi: 10.1093/europace/eus407. Epub 2012 Dec 14.

DOI:10.1093/europace/eus407

PMID:23243130

Abstract

摘要

相似文献

Yes to cardiac devices. But at what cost?

Europace. 2013 Mar;15(3):313-4. doi: 10.1093/europace/eus407. Epub 2012 Dec 14.

What costs matter? Rethinking social costs of new device technologies.

Europace. 2013 Nov;15(11):1538-9. doi: 10.1093/europace/eut139. Epub 2013 Jul 5.

Cost-of-illness study of patients subjected to cardiac rhythm management devices implantation: results from a single tertiary centre.

Europace. 2013 Mar;15(3):366-75. doi: 10.1093/europace/eus363. Epub 2012 Nov 12.

Making the Most of Cardiac Device Remote Management: Towards an Actionable Care Model.

Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009497. doi: 10.1161/CIRCEP.120.009497. Epub 2021 Mar 4.

Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.

Europace. 2018 Dec 1;20(12):1974-1980. doi: 10.1093/europace/eux387.

Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness.

Annu Rev Med. 2017 Jan 14;68:1-13. doi: 10.1146/annurev-med-043015-123540. Epub 2016 Sep 21.

Cardiac electrophysiology: a cost-effective approach.

Clin Cardiol. 1996 Jul;19(7):575-8. doi: 10.1002/clc.4960190710.

Summaries for patients. The cost-effectiveness of cardiac resynchronization therapy for heart failure.

Ann Intern Med. 2004 Sep 7;141(5):I29. doi: 10.7326/0003-4819-141-5-200409070-00104. Epub 2004 Aug 16.

New device indications: practice and cost implications in Europe.

Card Electrophysiol Rev. 2003 Jan;7(1):49-53. doi: 10.1023/a:1023691023403.

Cardiac electrophysiology in Lebanon.

Heart Rhythm. 2010 Dec;7(12):1914. doi: 10.1016/j.hrthm.2010.10.003. Epub 2010 Oct 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Yes to cardiac devices. But at what cost?

Europace. 2013 Mar;15(3):313-4. doi: 10.1093/europace/eus407. Epub 2012 Dec 14.

What costs matter? Rethinking social costs of new device technologies.

Europace. 2013 Nov;15(11):1538-9. doi: 10.1093/europace/eut139. Epub 2013 Jul 5.

Cost-of-illness study of patients subjected to cardiac rhythm management devices implantation: results from a single tertiary centre.

Europace. 2013 Mar;15(3):366-75. doi: 10.1093/europace/eus363. Epub 2012 Nov 12.

Making the Most of Cardiac Device Remote Management: Towards an Actionable Care Model.

Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009497. doi: 10.1161/CIRCEP.120.009497. Epub 2021 Mar 4.

Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.

Europace. 2018 Dec 1;20(12):1974-1980. doi: 10.1093/europace/eux387.

Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness.

Annu Rev Med. 2017 Jan 14;68:1-13. doi: 10.1146/annurev-med-043015-123540. Epub 2016 Sep 21.

Cardiac electrophysiology: a cost-effective approach.

Clin Cardiol. 1996 Jul;19(7):575-8. doi: 10.1002/clc.4960190710.

Summaries for patients. The cost-effectiveness of cardiac resynchronization therapy for heart failure.

Ann Intern Med. 2004 Sep 7;141(5):I29. doi: 10.7326/0003-4819-141-5-200409070-00104. Epub 2004 Aug 16.

New device indications: practice and cost implications in Europe.

Card Electrophysiol Rev. 2003 Jan;7(1):49-53. doi: 10.1023/a:1023691023403.

Cardiac electrophysiology in Lebanon.

Heart Rhythm. 2010 Dec;7(12):1914. doi: 10.1016/j.hrthm.2010.10.003. Epub 2010 Oct 29.